Secondary Logo

Journal Logo

Online College Publications

Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity

Author Information
doi: 10.1097/AOG.0000000000002045
  • Free


Recommendations and Conclusions

The American College of Obstetricians and Gynecologists (the College) makes the following recommendations and conclusions:

  • In 2015, the birth rate among U.S. adolescents and young adults (aged 15–19 years) reached a historic low. Pregnancy in adolescents has decreased largely because adolescents are becoming more effective contraceptive users.
  • A reproductive justice framework for contraceptive counseling and access is essential to providing equitable health care, accessing and having coverage for contraceptive methods, and resisting potential coercion by health care providers.
  • The College supports access for adolescents and young adults to all contraceptive methods approved by the U.S. Food and Drug Administration (FDA).
  • Because of the safety and effectiveness of long-acting reversible contraceptive (LARC) methods, the College and the American Academy of Pediatrics (AAP) endorse the use of intrauterine devices (IUDs) and implants as contraceptive options for adolescents.
  • The College, the Centers for Disease Control and Prevention (CDC), and AAP also recommend that LARC methods be discussed with pregnant adolescents.
  • For adolescents who choose a LARC method, initiation should be offered immediately after delivery, pregnancy loss, or abortion.
  • Where allowed, obstetrician–gynecologists should provide adolescents the opportunity to discuss their reproductive goals and contraceptive needs without a parent or guardian present for at least part of the visit.
  • The College supports the use of evidence-based, medically accurate, age-appropriate sexuality education as an integral part of health education.
  • Dual method use—pairing condoms with more effective contraceptive methods to protect against sexually transmitted infections (STIs) and unwanted pregnancy—is the ideal contraceptive practice for adolescents.


In 2015, the birth rate among U.S. adolescents and young adults (aged 15–19 years) reached a historic low at 22.3 per 1,000 women (1). Decreases have been dramatic: between 2007 and 2015, birth rates fell 54% for females aged 15–17 years and 43% for women aged 18–19 years(1). Adolescent pregnancy rates have decreased in all 50 states and across all racial and ethnic groups. Despite decreases, racial and ethnic disparities persist, with higher rates of birth and abortion among black and Hispanic adolescents compared with non-Hispanic white adolescents (2). The CDC ( and the Guttmacher Institute ( publish up-to-date adolescent pregnancy, birth, and abortion rates.

Despite decreases, the United States continues to have the highest adolescent pregnancy and birth rates among developed countries with available data (3). Childbearing is more likely among socioeconomically disadvantaged adolescents and contributes to continued socioeconomic effects for the mother, her family, and society. Adolescent childbearing is a complex issue; although it is associated with socioeconomic disadvantage, social determinants of health likely play a more causal role. Thus, reducing adolescent childbearing will not fully address the socioeconomic disadvantage that exists for many adolescents. Sixty percent of adolescent mothers do not graduate from high school and only 2% complete college by the age of 30 years (4). Of all births among adolescents, 17% are repeat births (5), compounding the educational and economic consequences of adolescent childbearing. Adolescents who bear a second or third child are less likely to complete high school or return to work than those with one child (6, 7). In 2010, births among adolescents cost an estimated $9.4 billion more than if they had occurred to women aged 20–21 years (8).

Decreases in Adolescent Pregnancy Rates

In adolescents, two factors, 1) contraceptive use and 2) sexual activity, can affect the pregnancy rate. Both factors are thought to have contributed to the notable decrease in the adolescent pregnancy rate since the adolescent pregnancy rate peaked in 1990 (2, 9). Between 1995 and 2002, a small proportion of the decrease in adolescent pregnancy can be attributed to an increase in the age at first intercourse and a decrease in the number of adolescents who reported ever having sex (9, 10). Between 2003 and 2011, the number of adolescents ever having sex (45.6–47.7%) did not change (9, 10). The most rapid decrease in adolescent pregnancy occurred from 2008 to 2011 (11). Data suggest that changes in sexual activity are unlikely to have contributed significantly to this rapid decrease (12, 13).

Pregnancy in adolescents has decreased largely because adolescents are becoming more effective contraceptive users (9, 13). Use of LARC methods in contraceptive users who were 15–19 years of age increased from 1.5% in 2006–2008 (14) to 4.3% in 2009–2012 (15). Although modest, this increase represents a tripling in the use of LARC methods among adolescents. Between 2007 and 2012, significant increases in the use of any method at last sexual experience in the prior 3 months (78–86%, P=.046) and the use of multiple methods (25–37%, P=.046) were noted. Data from 2011 to 2013 demonstrate that more adolescents used contraception at the time of first intercourse; nearly 80% of females used a birth control method the first time they had sex compared with approximately one half of females before 1985 (12, 16). The social and behavioral factors that motivated adolescents to become more effective contraceptive users and less sexually active are unclear. Involvement in school activities, educational and career aspirations, mentoring programs, economic fluctuations, childbearing norms, contraceptive coverage under the Affordable Care Act, and the availability of health information through the Internet and television all have been hypothesized to play a role.

Contraceptive Use in Adolescents

The College supports access for adolescents to all contraceptive methods approved by the FDA. In the absence of contraindications (17), patient choice should be the principal factor in prescribing one method of contraception over another. To help the patient make this choice, the obstetrician–gynecologist should do the following:

  • Elicit the patient’s reproductive goals and values and support her ability to honor those goals and values with her contraceptive decisions
  • Identify structural inequalities that affect an adolescent’s reproductive health and autonomy
  • Discuss contraceptive efficacy and failure rates
  • Fully explain potential adverse effects and risks of all methods
  • Describe ease of use and noncontraceptive benefits
  • Explain the use of barrier methods to reduce the risk of STI transmission when nonbarrier contraceptive methods are used

When engaging in shared decision making regarding contraceptive use, obstetrician–gynecologists should be aware of and address their own biases, work to empower patients, and strive for equitable outcomes for all patients regardless of age, race or ethnicity, class, or socioeconomic status (18). A reproductive justice framework for contraceptive counseling and access is essential to providing equitable health care, accessing and having coverage for contraceptive methods, and resisting potential coercion by health care providers. The framework of reproductive justice connects family planning and other aspects of sexual and reproductive health with the disparities and complexities that affect patients’ lives. Furthermore, it encourages gynecologic health care providers to examine issues of bias and coercion and advocate for equitable access and change (19).

Adolescents face unique barriers in accessing contraceptive services, including concerns about confidentiality and cost. Adolescents’ legal rights to confidential contraceptive services vary by state and change over time. Where allowed, obstetrician–gynecologists should provide adolescents the opportunity to discuss their reproductive goals and contraceptive needs without a parent or guardian present for at least part of the visit. Additionally, obstetrician–gynecologists may refer patients to Title-X-funded clinics for confidential contraceptive services if they are unable to provide confidential care (20). The Guttmacher Institute provides up-to-date individual state-level information on consent laws, confidentiality of minors’ health information, and minors’ access to contraceptive services at

Adolescents who discuss sexuality and contraception with a parent or guardian are more likely to use contraception consistently and are less likely to become pregnant (21, 22). Although parental involvement should be encouraged when a supportive parent or guardian is available, pregnancy intention and the decision to start or stop contraception are highly individual and complex. Just as adolescents should have access to the full range of contraceptives, including LARC methods, they should be able to decline and discontinue any method on their own, without barriers.

Fear of a pelvic examination may prevent adolescents from seeking contraception (23). A pelvic examination is seldom necessary, except for IUD insertion (24). Whether recent changes in practice guidelines regarding pelvic examination in adolescents have diminished concerns in this population is currently unknown. National data indicate a decrease in the number of young women who have had a pelvic examination who are using effective contraception (eg, oral contraceptive pills [OCPs], depot medroxyprogesterone acetate [DMPA], the patch, or the ring) (25).

The College supports access for adolescents and young adults to all contraceptive methods approved by the FDA. These methods include IUDs, implants, DMPA, combined hormonal contraceptives, as well as condoms.

Long-Acting Reversible Contraception

Because of the safety and effectiveness of LARC methods, the College and the AAP endorse the use of IUDs and implants as contraceptive options for adolescents (26, 27). Satisfaction with and continuation of LARC methods are high among adolescents. Continuation at 12 months was 81% for LARC methods (75.6% for the copper IUD, 80.6% for the levonorgestrel IUD, 82.2% for the implant) compared with 44% for non-LARC methods (47.3% for DMPA, 46.7% for OCPs, 40.9% for the patch, 31.0% for the ring) among 15–19 year olds (28).

The College, CDC, and AAP also recommend that LARC methods be discussed with pregnant adolescents. For adolescents who choose a LARC method, initiation should be offered immediately after delivery, pregnancy loss, or abortion (26, 27, 29). As contraindications to immediate placement are uncommon, obstetrician–gynecologists should counsel women about the convenience and effectiveness of immediate postpregnancy LARC, as well as the benefits of lengthening interpregnancy intervals. Additional College guidance offers strategies to improve access to LARC methods and to all contraceptives under the Affordable Care Act (30) and to immediate postpartum insertion of IUDs and implants (31).

Patient and health care provider misconceptions about LARCs continue to pose a barrier to LARC methods. Although most clinicians consider LARC methods to be safe, some still do not provide these methods to adolescents. Adolescents themselves have only a modest awareness of LARC methods. Counseling by an obstetrician–gynecologist or other qualified health care professional is critical in increasing access to LARC methods, particularly because 85% of young women (aged 18–29 years) reported they trusted a clinician, other health care provider, or other professional source the most for birth control information (32). Contraceptive counseling programs that engage adolescents in shared decision making show high levels of LARC method selection (27, 33). The College’s clinical guidance, practice resources, and educational resources on LARC can be found at Guidelines from the CDC on providing quality family planning services can be found at (34). See For More Informa-tion for additional relevant resources.

Depot Medroxyprogesterone Acetate

Injectable contraception (DMPA) has a convenient dosage schedule, which makes it a good method for many adolescents. When cost and access barriers are eliminated, women who received repeat injections of DMPA within the recommended 3-month period had very low pregnancy rates, similar to those of LARC methods (35). Losses in bone mineral density appear to be fully reversible and do not contribute to fracture risk. Concerns about bone mineral density prompted the FDA to place a “black box” warning on DMPA, cautioning against use beyond 2 years unless no other contraceptive method was acceptable. However, evidence suggests that DMPA may be used indefinitely by adolescents or older women. Obstetrician–gynecologists should address adolescents’ questions and concerns regarding the “black box” warning (36).

Combined Hormonal Contraceptives

Combined hormonal contraceptives contain estrogen and progestin and include OCPs, the patch, and the ring. Although they have a higher failure rate than LARC methods or DMPA, combined hormonal contraceptives have a beneficial effect on a number of conditions that can affect an adolescent’s quality of life, including dysmenorrhea, benign breast disease, iron deficiency anemia, acne, and menstrual irregularity. Oral contraceptive pills are a popular method among adolescents with 54% of sexually active 15–19 year olds reporting that they used this method for a time (12). One-year continuation rates for OCPs are 32.7 per 100 woman-years, 10.9 per 100 woman-years for the patch, and 29.4 per 100 woman-years for the ring. Difficulties with use, in addition to adverse effects, are two of the most common reasons adolescents discontinue combined hormonal methods (37).

“Quick Start” Initiation

Because delays in contraceptive method initiation may be a barrier to contraception for adolescents, same day initiation (“quick start”) should be considered when appropriate. All contraceptive methods (including LARC methods) can be started anytime, including on the day of the visit, if there is reasonable certainty that the patient is not pregnant. Risk of pregnancy can be assessed using patient history (eg, less than or equal to 7 days after the start of normal menses or has not had sexual intercourse since the start of last normal menses) and urine pregnancy tests (24). When there is uncertainty about pregnancy, the benefits of starting the implant, DMPA, combined hormonal contraceptives, and progestin-only pills likely exceed any risk. Thus, starting a contraceptive method should be considered at any time, and a pregnancy test should be repeated in 2–4 weeks. If there is uncertainty about pregnancy, an IUD should not be inserted until the health care provider is reasonably certain that the patient is not pregnant. Additional information about initiating specific contraceptive methods and use of “back up” contraception is available in the CDC’s U.S. Selected Practice Recommendations for Contraceptive Use (24). Obstetrician–gynecologists should be able to provide anticipatory guidance for adolescents and their parents or guardians regarding expected bleeding effects and possible menstrual changes with various methods.


Strategies to promote adherence to the pill, patch, ring, and DMPA include cell phone or electronic reminders and online programs that provide the user with daily, weekly, monthly, or quarterly text messages ( Given the familiarity of adolescents with online programs and text messaging, these strategies have the potential to increase adherence. However, more high-quality studies are needed to establish the effectiveness of these programs (38).

Examples of Effective Contraceptive Programs

The public health benefit of improved access to contracep-tion was demonstrated in the Contraceptive CHOICE project ( When provided with structured counseling in which the most effective methods were discussed first and access to all methods was provided at no cost, 71.5% of adolescents in the CHOICE cohort selected a LARC method (39). Overall, sexually active adolescents had a pregnancy rate of 34.0, birth rate of 19.4, and abortion rate of 9.7 per 1,000, all of which are lower than national averages (39). Unintended pregnancy was 22 times higher among non-LARC users compared with LARC users (35).

The Office of Adolescent Health, Office of Popula-tion Affairs, and the CDC have identified evidence-based community programs to prevent adolescent pregnancy. Obstetrician–gynecologists and other women’s health care providers are encouraged to participate in suchprograms in their communities. The National Campaign to Prevent Teen and Unplanned Pregnancy also maintains a database of effective adolescent pregnancy prevention programs at

Title X of the Public Health Service Act is a federal program that provides infrastructure funding to community-based family planning centers, as well as funds for direct client services. Each dollar spent on Title X services saves an estimated $7 in taxpayer costs (40). In 2014, 3.7 million female clients were served by Title X, which resulted in the avoidance of 904,000 unintended pregnancies, 439,000 unplanned births, and 326,000 abortions (41). When the Colorado Family Planning Initiative focused its Title X program on increasing LARC provision through health care provider training and increased financing for LARC, use of LARC methods increased from 5% in 2009 to 19% in 2011, and substantial changes in adolescent pregnancy rates occurred (42). Among low-income residents who lived in counties with a Title X clinic, the observed adolescent birth rate was nearly one-third lower than the projected rate and the number of high-risk births decreased, presumably because of prevention of unintended pregnancy.

Promoting Condom Use and Dual Method Use Among Adolescents

In 2011–2013, 97% of sexually active female adolescents and young adults aged 15–19 years had their partners use the male condom at least once (12). The high typical-use failure rate of male (18%) and female (21%) condoms make them less effective contraceptive methods (43), although they also provide protection against STIs. Condom use requires the ability to communicate and negotiate with a partner, admit to the risk of STI acquisition, and initiate use at time of coitus, which can be challenging for adolescents (44). Dual method use—pairing condoms with more effective contraceptive methods—to protect against STIs and unwanted pregnancy is the ideal contraceptive practice for adolescents. The rate of dual use among adolescents is 22.8% and is lowest among LARC users (45). When adolescents initiate highly effective methods, the obstetrician–gynecologist should reinforce the role of condoms in preventing STI acquisition. Few behavioral intervention trials have demonstrated success in increasing dual use, which suggests the need for additional strategies (46).

The availability of condoms in retail stores and pharmacies without a prescription does not always translate to ready access for adolescents. Condoms kept behind a counter and requiring assistance from a store clerk are deterrents to adolescents. Obstetrician–gynecologists are encouraged to provide condoms within their offices, teach adolescents how to properly use condoms, and support availability within their communities. See For More Information for relevant resources.

The College and AAP support school-based condom availability programs (47). The effect of school availability programs on condom use is mixed. Some studies show increased use of condoms but others report nonsignificant changes (48, 49). Studies of school-based condom availability programs have found increased condom use when adolescents can obtain condoms in school through counselors, nurses, teachers, vending machines, or baskets (50, 51). Concern that these programs will hasten initiation of sex and increase sexual activity are unfounded (50–52).

Education for Adolescent Pregnancy Prevention

Comprehensive sexuality education programs, clinic-based programs, school-based health centers, and condom availability programs have all been cited as potential contributors to the decreases in adolescent pregnancy, although none has been implemented on a large enough scale in the United States to be solely responsible for decreases in adolescent pregnancy. See the College’s Committee Opinion 678, Comprehensive Sex Education, for more information (53).

Adolescents who participate in comprehensive sexuality education delay the initiation of sex and have increased condom and contraceptive use (54). Com-paratively, abstinence-only programs are ineffective at delaying sexual initiation (54, 55). Most students who have taken abstinence pledges have sex before marriage (56). Those who do have sex before marriage are less likely than similar nonpledgers to use condoms or contraceptives consistently and are more likely to experience nonmarital pregnancy and acquire human papillomavirus infection (56, 57). The College and AAP support the use of evidence-based, medically accurate, age-appropriate sexuality education as an integral part of health education (53, 58). Fewer than one half of all states mandate sexuality education and even in states that do have a mandate, the content varies significantly by county and school. Up-to-date state-level policy information can be found at Guttmacher’s State Center (

Clinic-based programs provide comprehensive sexuality education specifically targeted to adolescents in a clinic setting. Most programs involve fewer than 10 contact hours with adolescents and physicians or health educators (59). Most studies of clinic-based programs targeted female-only or male-only participants, although some included both. Clinic-based programs can be one-on-one encounters or may incorporate group sessions. Evaluation of different programs reported variable effects. Although no programs found a delay of sexual initiation, many reported decreased sexual frequency, decreased number of partners, increased condom use, increased contraceptive use, decreased STI acquisition, and decreased pregnancies or births (59). School-based health centers that also supply contraceptives are well-situated to provide convenient, confidential care to males and females. Studies show that such centers do not increase student sexual activity and may increase the use of contraception among students (48, 60).

Looking Forward

Despite positive trends, the United States continues to have the highest adolescent pregnancy rate among industrialized countries with data. Racial and ethnic disparities in adolescent pregnancy rates continue to exist, as do state-based differences in pregnancy, birth, and abortion rates. Successful programs that resulted in measurable changes in adolescent contraceptive practices and sexual behavior have been described, but not implemented uniformly nor supported by policy improvements. More research is needed to determine which programs are most effective and which programs do not work. Continued efforts are integral to further advance positive trends.

For More Information

The American College of Obstetricians and Gynecologists has identified additional resources on topics related to this document that may be helpful for ob-gyns, other health care providers, and patients. You may view these resources at

These resources are for information only and are not meant to be comprehensive. Referral to these resources does not imply the American College of Obstetricians and Gynecologists’ endorsement of the organization, the organization’s website, or the content of the resource. The resources may change without notice.


1. Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Mathews TJ. Births: final data for 2015. Natl Vital Stat Rep 2017;66:1. Available at: Retrieved March 3, 2017.
2. Kost K, Maddow-Zimet I. U.S. teenage pregnancies, births and abortions, 2011: state trends by age, race and ethnicity. New York (NY): Guttmacher Institute; 2016. Available at: Retrieved November 7, 2016.
3. Sedgh G, Finer LB, Bankole A, Eilers MA, Singh S. Adolescent pregnancy, birth, and abortion rates across countries: levels and recent trends. J Adolesc Health 2015;56:223–30.
4. Shuger L. Teen pregnancy and high school dropout: what communities can do to address these issues. Washington, DC: National Campaign to Prevent Teen and Unplanned Pregnancy; 2012. Available at: Retrieved November 7, 2016.
5. Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2014. Natl Vital Stat Rep 2015;64:1–64.
6. Polit DF, Kahn JR. Early subsequent pregnancy among economically disadvantaged teenage mothers. Am J Public Health 1986;76:167–71.
7. Horwitz SM, Klerman LV, Kuo HS, Jekel JF. School-age mothers: predictors of long-term educational and economic outcomes. Pediatrics 1991;87:862–8.
8. National Campaign to Prevent Teen and Unplanned Pregnancy. Counting it up: the public costs of teen childbearing. Available at: Retrieved November 7, 2016.
9. Boonstra HD. What is behind the declines in teen pregnancy rates? Guttmacher Policy Rev 2014;17(3):15–21.
10. Kann L, Kinchen S, Shanklin SL, Flint KH, Kawkins J, Harris WA, et al. Youth risk behavior surveillance—United States, 2013. Centers for Disease Control and Prevention (CDC) [published erratum appears in MMWR Morb Wkly Rep 2014;63:576]. MMWR Suppl 2014;63:1–168.
11. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374:843–52.
12. Martinez GM, Abma JC. Sexual activity, contraceptive use, and childbearing of teenagers aged 15–19 in the United States. NCHS Data Brief 2015;(209):1–8.
13. Lindberg L, Santelli J, Desai S. Understanding the decline in adolescent fertility in the United States, 2007–2012. J Adolesc Health 2016;59:577–83.
14. Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive methods in the United States, 2007–2009. Fertil Steril 2012;98:893–7.
15. Kavanaugh ML, Jerman J, Finer LB. Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009–2012. Obstet Gynecol 2015;126:917–27.
16. Mosher WD, Jones J. Use of contraception in the United States: 1982–2008. Vital Health Stat 23 2010;(29):1–44.
17. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1–103.
18. Gubrium AC, Mann ES, Borrero S, Dehlendorf C, Fields J, Geronimus AT, et al. Realizing reproductive health equity needs more than long-acting reversible contraception (LARC). Am J Public Health 2016;106:18–9.
19. Gilliam ML, Neustadt A, Gordon R. A call to incorporate a reproductive justice agenda into reproductive health clinical practice and policy. Contraception 2009;79:243–6.
20. U.SDepartment of Health and Human Services, Office of Population Affairs. OPA program policy notice 2014-01—confidential services to adolescents. Washington, DC: HHS; 2014. Available at: Retrieved January 25, 2017.
21. Amialchuk A, Gerhardinger L. Contraceptive use and pregnancies in adolescents’ romantic relationships: role of relationship activities and parental attitudes and communication. J Dev Behav Pediatr 2015;36:86–97.
22. Crosby RA, DiClemente RJ, Wingood GM, Harrington K, Davies S, Hook EW 3rd, et al. Low parental monitoring predicts subsequent pregnancy among African-American adolescent females. J Pediatr Adolesc Gynecol 2002;15:43–6.
23. Braverman PK, Breech L. Clinical report—gynecologic examination for adolescents in the pediatric office setting. American Academy of Pediatrics, Committee on Adolescence. Pediatrics 2010;126:583–90.
24. Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1–66.
25. Vinekar KS, Vahratian A, Hall KS, West BT, Caldwell A, Bell JD, et al. Cervical cancer screening, pelvic examinations, and contraceptive use among adolescent and young adult females. J Adolesc Health 2015;57:169–73.
26. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion No. 539. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:983–8.
27. Contraception for adolescents. Committee on Adolescence. Pediatrics 2014;134:e1244–56.
28. Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol 2012;120:1298–305.
29. Vital signs: repeat births among teens—United States, 2007–2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2013;62:249–55.
30. Access to contraception. Committee Opinion No. 615. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:250–5.
31. Immediate postpartum long-acting reversible contraception. Committee Opinion No. 670. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e32–7.
32. Kaye K, Suellentrop K, Sloup C. The fog zone: how misper-ceptions, magical thinking, and ambivalence put young adults at risk for unplanned pregnancy. Washington, DC: National Campaign to Prevent Teen and Unplanned Pregnancy; 2009. Available at: Retrieved November 7, 2016.
33. Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012;120:1291–7.
34. Gavin L, Moskosky S, Carter M, Curtis K, Glass E, Godfrey E, et al. Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2014;63:1–54.
35. Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998–2007.
36. Depot medroxyprogesterone acetate and bone effects. Committee Opinion No. 602. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;123:1398–402.
37. Raine TR, Foster-Rosales A, Upadhyay UD, Boyer CB, Brown BA, Sokoloff A, et al. One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives. Obstet Gynecol 2011;117:363–71.
38. Smith C, Gold J, Ngo TD, Sumpter C, Free C. Mobile phone-based interventions for improving contraception use. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD011159.
39. Secura GM, Madden T, McNicholas C, Mullersman J, Buckel CM, Zhao Q, et al. Provision of no-cost, long-acting contraception and teenage pregnancy [published erratum appears in N Engl J Med 2014;372:297]. N Engl J Med 2014;371:1316–23.
40. Frost JJ, Sonfield A, Zolna MR, Finer LB. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program. Milbank Q 2014;92:696–749.
41. Frost JJ, Frohwirth L, Zolna MR. Contraceptive needs and services, 2014 update. New York (NY): Guttmacher Institute; 2016. Available at: Retrieved January 4, 2017.
42. Ricketts S, Klingler G, Schwalberg R. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. Perspect Sex Reprod Health 2014;46: 125–32.
43. Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404.
44. Williams RL, Fortenberry JD. Update on adolescent condom use. Curr Opin Obstet Gynecol 2011;23:350–4.
45. Eisenberg DL, Allsworth JE, Zhao Q, Peipert JF. Correlates of dual-method contraceptive use: an analysis of the National Survey of Family Growth (2006–2008). Infect Dis Obstet Gynecol 2012;2012:717163.
46. Lopez LM, Stockton LL, Chen M, Steiner MJ, Gallo MF. Behavioral interventions for improving dual-method contraceptive use. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD010915.
47. Condom use by adolescents. American Academy of Pediatrics, Committee on Adolescence. Pediatrics 2013; 132:973–81.
48. Hyde JS, editor. Promoting sexual health and responsible sexual behavior [special issue]. J Sex Res 2002;39(1).
49. De Rosa CJ, Jeffries RA, Afifi AA, Cumberland WG, Chung EQ, Kerndt PR, et al. Improving the implementation of a condom availability program in urban high schools. J Adolesc Health 2012;51:572–9.
50. SM Ledsky R, Goodenow C, Sawyer R, Lohrmann D, Windsor R. Condom availability programs in Massachusetts high schools: relationships with condom use and sexual behavior. Am J Public Health 2003;93:955–62.
51. Guttmacher S, Lieberman L, Ward D, Freudenberg N, Radosh A, Des Jarlais D. Condom availability in New York City public high schools: relationships to condom use and sexual behavior. Am J Public Health 1997;87:1427–33.
52. Kirby DB, Laris BA, Rolleri LA. Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world. J Adolesc Health 2007;40:206–17.
53. Comprehensive sexuality education. Committee Opinion No. 678. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e227–30.
54. Kirby DB. The impact of abstinence and comprehensive sex and STD/HIV education programs on adolescent sexual behavior. Sex Res Social Policy 2008;5:18–27.
55. Trenholm C, Devaney B, Fortson K, Quay L, Wheeler J, Clark M. Impacts of four Title V, Section 510 abstinence education programs: final report. Princeton (NJ): Mathematica Policy Research; 2007. Available at: Retrieved November 7, 2016.
56. Bruckner H, Bearman P. After the promise: the STD consequences of adolescent virginity pledges. J Adolesc Health 2005;36:271–8.
57. Paik A, Sanchagrin KJ, Heimer K. Broken promises: abstinence pledging and sexual and reproductive health. J Marriage Fam 2016;78:546–61.
58. Breuner CC, Mattson G. Sexuality education for children and adolescents. Committee on Adolescence, Committee on Psychosocial Aspects of Child and Family Health. Pediatrics 2016; DOI: 10.1542/peds.2016-1348.
59. Manlove J, Fish H, Moore KA. Programs to improve adolescent sexual and reproductive health in the US: a review of the evidence. Adolesc Health Med Ther 2015;6:47–79.
60. Minguez M, Santelli JS, Gibson E, Orr M, Samant S. Reproductive health impact of a school health center. J Adolesc Health 2015;56:338–44.
© 2017 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.